Christine M Blasey
Affiliation: Stanford University
- A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interactionChristine M Blasey
Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, United States
Contemp Clin Trials 30:284-8. 2009....
- Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in ratsJoseph K Belanoff
Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park, CA 94061, United States
Eur J Pharmacol 655:117-20. 2011..Both glucocorticoid receptor antagonists significantly attenuated the weight gain induced by olanzapine in a dose dependent manner. Differences in weight gain were not attributable to decreased food intake...
- Mifepristone treatment of olanzapine-induced weight gain in healthy menColeman Gross
Corcept Therapeutics, Menlo Park, CA 94025, USA
Adv Ther 26:959-69. 2009..The objective of this study was to determine if mifepristone, a glucocorticoid receptor antagonist, could prevent olanzapine-induced weight gain...